Controversies about extended-spectrum and AmpC beta-lactamases.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Controversies about extended-spectrum and AmpC beta-lactamases.
  • Published Date:

    2001 Mar-Apr

  • Source:
    Emerg Infect Dis. 7(2):333-336.
Filetype[PDF-54.50 KB]


Details:
  • Alternative Title:
    Emerg Infect Dis
  • Personal Author:
    Thomson, K. S.
  • Description:
    Many clinical laboratories have problems detecting extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC beta-lactamases. Confusion exists about the importance of these resistance mechanisms, optimal test methods, and appropriate reporting conventions. Failure to detect these enzymes has contributed to their uncontrolled spread and sometimes to therapeutic failures. Although National Committee for Clinical Laboratory Standards recommendations exist for detecting ESBL- producing isolates of Escherichia coli and Klebsiella spp., no recommendations exist for detecting ESBLs in other organisms or for detecting plasmid-mediated AmpC beta-lactamases in any organisms. Clinical laboratories need to have adequate funding, equipment, and expertise to provide a rapid and clinically relevant antibiotic testing service in centers where these resistance mechanisms are encountered.
  • Subject:
  • Document Type:
    Journal Article
  • Collection(s):
    Emerging Infectious Diseases
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 765.92 KB]
    Personal Author:
    Nordmann, Patrice; Naas, Thierry; Poirel, Laurent;
    Published Date:
    Oct 2011
    Source:
    Emerg Infect Dis. 17(10):1791-1798.
    Description:
    Carbapenemases increasingly have been reported in Enterobacteriaceae in the past 10 years. Klebsiella pneumoniae carbapenemases have been reported in the United States and then worldwide, with a marked endemicity at least in the United States and Gre...
    File Type:
    Filetype[PDF - 765.92 KB]
  2. Filetype[PDF - 77.67 KB]
    Personal Author:
    Brooks, Richard B.; Walters, Maroya; Forsberg, Kaitlin; Vaeth, Elisabeth; Woodworth, Kate; Vallabhaneni, Snigdha;
    Published Date:
    August 02 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(30):664-666
    Description:
    Candida auris is an emerging drug-resistant yeast that causes outbreaks in health care facilities; cases have been reported from approximately 30 countries. U.S. cases of C. auris are likely the result of importation from abroad followed by extensive...
    File Type:
    Filetype[PDF - 77.67 KB]
  3. Filetype[PDF - 193.49 KB]
    Personal Author:
    Johnson, J. Kristie; Wilson, Lucy E.; Zhao, LiCheng; Richards, Katherine; Thom, Kerri A.; Harris, Anthony D.;
    Corporate Authors:
    Maryland MDRO Prevention Collaborative
    Published Date:
    Apr 2014
    Source:
    Infect Control Hosp Epidemiol. 35(4):443-445.
    File Type:
    Filetype[PDF - 193.49 KB]
  4. Filetype[PDF - 347.99 KB]
    Personal Author:
    Myat, Tin O.; Hannaway, Rachel F.; Zin, Khwar N.; Htike, Wah W.; Win, Kyu K.; Crump, John A.; Murdoch, David R.; Ussher, James E.;
    Published Date:
    May 2017
    Source:
    Emerg Infect Dis. 23(5):857-859.
    Description:
    Among 42 gram-negative bloodstream isolates from inpatients in 3 hospitals in Yangon, Myanmar, admitted during July-December 2014, 16 (38%) were extended-spectrum β-lactamase-producing Enterobacteriaceae and 6 (14%) produced carbapenemase. The high ...
    File Type:
    Filetype[PDF - 347.99 KB]
  5. Filetype[PDF - 1.18 MB]
    Corporate Authors:
    Healthcare Infection Control Practices Advisory Committee (U.S.). Centers for Disease Control and Prevention (U.S.).
    Published Date:
    March 20, 2009
    Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(10):256-60.
    Description:
    Infection with carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae is emerging as an important challenge in health-care settings. Currently, carbapenem-resistant Klebsiella pneumoniae (CRKP) is the species of C...
    Status:
    current
    File Type:
    Filetype[PDF - 1.18 MB]